GEN Edge - Latest

Latest

All

GEN Edge

Going Public: Doudna’s Dream Team Launches Groundbreaking Sickle Cell Trial

Drug Discovery

Novartis, PTC Ink Up-to-$2.9B Huntington’s Disease Collaboration

Drug Discovery

Trump to Nominate Makary for FDA Commissioner

Drug Discovery

StockWatch: Moderna Seeks to Reassure Investors on RFK Jr.

Bioprocessing

Thermo Fisher’s Accelerator Expands CRO, CDMO Services

Artificial Intelligence

Trans-Atlantic Triumph: AI Drug Pioneers Recursion, Exscientia Combine

Drug Discovery

Schrödinger, Novartis Ink Up-to-$2.3B Collaboration, Software Agreement

Drug Discovery

StockWatch: Vaccine, ETF Shares Drop as Trump Chooses RFK Jr. for HHS

Drug Discovery

Treehill CEO Sees Positives for Biopharma in Trump’s Re-Election

Artificial Intelligence

Insilico Plans Pivotal Trial for AI-Based IPF Candidate

Drug Discovery

StockWatch: Wall Street Weighs Trump Effect on Biopharma, from Vaccines to M&A

Drug Discovery

Supplier-Turned-Partner: Twist Joins Absci in AI Antibody Collaboration

Genome Editing

Patient Dies in Beam Trial of SCD Candidate; Company Cites Conditioning

Drug Discovery

Alzheimer’s Drug Shows Slower Cognitive Decline in Lower Tau Patients

Drug Discovery

StockWatch: Investors Hammer Lilly as GLP-1 Sales Miss Forecasts

OMICs

10x, Bruker Launch New Single Cell Products

Infectious Diseases

Recursion Advances AI-Based C. Diff Candidate to Phase II

Drug Discovery

Novartis, Monte Rosa Launch Up-to-$2.1B Molecular Glue Collaboration

Genome Editing

StockWatch: Sangamo Shares Surge on Shorter Pathway for Fabry Candidate

Cancer

New CEO Leads CRI’s Fight vs. Cancer: “People x Biology x Data”

Drug Discovery

Seaport Eyes Platform, Pipeline Growth with $225M Series B

Genome Editing

StockWatch: Wave’s RNA Editing Milestone Lifts Korro, ProQR

Drug Discovery

Immusoft Reports Promising Early Data for Lead Candidate in MPS I

Drug Discovery

Pfizer, Triana Launch Up-to-$1.5B+ Molecular Glue Collaboration

GEN Edge

StockWatch: Investors Unfazed by Illumina’s MiSeq Product Launches, Starboard’s $1B Stake in Pfizer

Artificial Intelligence

Recursion’s Fast-Track Road to Therapeutics Using AI-Based Maps of Biology

Drug Discovery

Diverse Genomes Make Medicine More Equitable

OMICs

Vizgen, Ultivue Merge, Further Consolidating Spatial Biology

Drug Discovery

StockWatch: BioAge, Orum Reflect Renewed Interest in IPOs

Drug Discovery

Kick Start: Judo Bio Takes a Page from Alnylam with $100M Launch